Referred to the House Committee on Foreign Affairs.
Email me when HR 7879 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 7879. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs the Secretary of State, working with the Health and Human Services Secretary and other agencies, to draft a plan within 18 months that brings in foreign governments and multilateral groups to help create and market qualified pandemic or epidemic medicines, especially those targeting antimicrobial‑resistant pathogens. It affects U.S. federal agencies, foreign partners, and private companies that could be involved in product development. The goal is to strengthen global health defenses and protect U.S. national security by preventing infectious‑disease threats before they reach U.S. shores.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 7879
3 free questions a day, no accountHistory
- Referred to the House Committee on Foreign Affairs.
- Introduced in House
Sponsors
- Rep. Levin, Mike [D-CA-49] (D) · sponsor
- Rep. Costa, Jim [D-CA-21] (D)
- Rep. Fitzpatrick, Brian K. [R-PA-1] (R)
- Rep. Valadao, David G. [R-CA-22] (R)
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 7879 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 7879 freeOr ask your AI assistant about HR 7879 directly:
Add to Claude, ChatGPT or Cursor